Status:
COMPLETED
Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Harvard Risk Management Foundation
National Cancer Institute (NCI)
Conditions:
Cancer
Severe Major Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research is to understand if it is helpful for patients with mental illness to be connected to a psychiatrist and case manager at the time of cancer diagnosis.
Detailed Description
It is challenging to cope with cancer. The investigators want to understand if it is helpful for patients with serious mental illness (SMI) to be connected to a psychiatrist and case manager when canc...
Eligibility Criteria
Inclusion
- Patient
- Age ≥ 18 years old; Value \_\_\_\_\_\_
- Verbal fluency in English
- Serious mental illness (Schizophrenia spectrum disorder, bipolar disorder, or major depressive disorder with prior psychiatric hospitalization) confirmed by study clinician at consent
- Invasive breast, lung, gastrointestinal, or head and neck cancer (suspected or confirmed Stage I-III, or Stage IV cancer that can be treated with curative intent according to judgment by the oncologist.)
- Medical, surgical, or radiation oncology consultation at MGH Cancer Center within the past 8 weeks or a referral placed to the MGH Cancer Center and planned or recommended follow-up
- Patient
Exclusion
- Have cognitive impairment severe enough to interfere with completing brief study assessments or providing informed consent (and does not have a guardian who can provide consent)
- Recurrence of the same cancer type
- Caregiver Participants
- Age ≥ 18 years old; Value \_\_\_\_\_\_
- Verbal fluency in English
- Identified or confirmed by the patient or guardian as a caregiver
- Caregiver may be a relative, friend, or community mental health staff upon whom the patient relies upon for support and who accompanies the patient to medical appointments
- The caregiver should either live with the patient or have in-person contact with the patient once per week (on average)
- Patient or guardian must provide permission to contact caregiver
Key Trial Info
Start Date :
December 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
185 Patients enrolled
Trial Details
Trial ID
NCT03360695
Start Date
December 11 2017
End Date
December 1 2022
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114